Ozdag Yagiz, Hayes Daniel S, Callahan Clarice, El Koussaify Jad, Warnick Eugene P, Foster Brian K, Klena Joel C, Grandizio Louis C
Department of Orthopaedic Surgery, Geisinger Commonwealth School of Medicine, Geisinger Musculoskeletal Institute, Danville, PA.
J Hand Surg Glob Online. 2023 Jul 22;5(6):779-783. doi: 10.1016/j.jhsg.2023.06.004. eCollection 2023 Nov.
Randomized controlled trials (RCTs) are frequently used in creating recommendations contained within clinical practice guidelines (CPGs). However, investigations outside of hand surgery have reported that RCTs within CPGs infrequently report complications and harms-related data. Our purpose was to assess adherence to complication reporting and harms-related outcomes contained in the Consolidated Standards for Reporting (CONSORT) Extension of Harms and Standards for Reporting of Diagnostic Accuracy Studies (STARD) reporting checklists for RCTs within the American Academy of Orthopaedic Surgery (AAOS) CPGs for carpal tunnel syndrome (CTS).
We identified all RCTs within the AAOS CTS CPGs. All therapeutic RCTs and diagnostic studies were included. We used the CONSORT Harms Checklist criteria to assess adherence to the reporting of adverse events for therapeutic RCTs and the STARD criteria to assess the diagnostic accuracy of the articles. We defined adequate compliance as adherence to ≥50% of the checklist items.
We identified 82 therapeutic RCTs and 90 diagnostic accuracy articles within the AAOS CTS CPG. For therapeutic RCTs, we found that the average compliance with the published checklists was 19%. For diagnostic studies, the average compliance with checklists was found to be 55%. Eleven therapeutic RCTs (13%) and 60 diagnostic studies (67%) were determined to have adequate compliance for the CONSORT and STARD checklists, respectively.
Randomized controlled trials in the AAOS CPGs for CTS have low compliance with the CONSORT Extension for Harms Checklist. Although the overall adherence to the items published in the STARD statement for diagnostic accuracy evaluation remains higher, future efforts should be made to improve the adherence rates to both checklists.
Improved standardization of complication reporting may aid in comparing outcomes across multiple clinical investigations of upper-extremity procedures.
随机对照试验(RCT)常用于制定临床实践指南(CPG)中的推荐意见。然而,手外科以外的研究报告称,CPG中的RCT很少报告并发症和危害相关数据。我们的目的是评估美国矫形外科医师学会(AAOS)腕管综合征(CTS)CPG中RCT对《综合报告标准(CONSORT)危害扩展版》和《诊断准确性研究报告标准(STARD)》报告清单中并发症报告和危害相关结果的遵循情况。
我们识别了AAOS CTS CPG中的所有RCT。纳入所有治疗性RCT和诊断性研究。我们使用CONSORT危害清单标准评估治疗性RCT不良事件报告的遵循情况,使用STARD标准评估文章的诊断准确性。我们将充分遵循定义为遵循清单项目的≥50%。
我们在AAOS CTS CPG中识别出82项治疗性RCT和90篇诊断准确性文章。对于治疗性RCT,我们发现对已发表清单的平均遵循率为19%。对于诊断性研究,发现对清单的平均遵循率为55%。分别确定11项治疗性RCT(13%)和60项诊断性研究(67%)对CONSORT和STARD清单有充分遵循。
AAOS CPG中关于CTS的随机对照试验对CONSORT危害扩展清单的遵循率较低。尽管在诊断准确性评估中对STARD声明中公布项目的总体遵循率仍然较高,但未来应努力提高对这两个清单的遵循率。
改善并发症报告的标准化可能有助于比较上肢手术的多项临床研究结果。